Suchergebnisse - "Tachibana, Takayoshi"

PubPharm (178)

11

Bridging to transplant and post-transplant maintenance therapy with FLT3 inhibitors in patients with relapsed or refractory FLT3 mutated acute myeloid leukemia

enthalten in: Hematology (Amsterdam, Netherlands) | 2023

von Hirose, N. | Tachibana, T. | Izumi, A. | +6

12

Treatment strategy at the decision for allogeneic transplantation in patients with myelodysplastic syndrome in the era of azacitidine : A KSGCT prospective study

enthalten in: Leukemia research | 2023

von Kako, S. | Kimura, S. | Wada, H. | +17

13

Allogeneic stem cell transplantation for children and adolescents/young adults with de novo blastic phase chronic myeloid leukemia in the tyrosine kinase inhibitor era

enthalten in: American journal of hematology | 2023

von Ishida, H. | Shimada, H. | Tanizawa, A. | +17

14

Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation

enthalten in: Bone marrow transplantation | 2023

von Kimura, S. | Shimizu, H. | Miyazaki, T. | +19

15

Clinical risk factors for patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplantation

enthalten in: Hematology (Amsterdam, Netherlands) | 2022

von Teshigawara-Tanabe, H. | Hagihara, M. | Aoki, J. | +13

16

Prognostic impact of complex karyotype on post-transplant outcomes of myelofibrosis

enthalten in: Hematological oncology | 2022

von Okada, Y. | Takenaka, K. | Murata, M. | +18

17

Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS : a KSGCT prospective study

enthalten in: Annals of hematology | 2022

von Najima, Y. | Tachibana, T. | Takeda, Y. | +17

18

Outcomes in patients with acute lymphoblastic leukemia who underwent second allogeneic hematopoietic cell transplantation for relapse after first transplantation

enthalten in: International journal of hematology | 2022

von Tachibana, T. | Tanaka, M. | Hagihara, M. | +3

19

Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study

enthalten in: Annals of hematology | 2022

von Najima, Y. | Tachibana, T. | Takeda, Y. | +17

20

Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study

enthalten in: Annals of hematology | 2022

von Najima, Y. | Tachibana, T. | Takeda, Y. | +17